Single Dosing Clinical Trial of HL151

Summary

The purpose of this study is to assess the pharmacokinetic characteristics of bepotastine after single oral administration of TALION tab, a IR formulation of bepotastine as reference drug and HL151, a SR formulation of bepotastine as test drug in healthy male adults. Additionally the safety and tolerability of two drugs will be evaluated.

Timeline

Start

2016-01-15

Primary completion

2016-02-12

Completion

2016-02-12

Drugs

Indications